DK325285A - Behandlingsmetode - Google Patents

Behandlingsmetode Download PDF

Info

Publication number
DK325285A
DK325285A DK325285A DK325285A DK325285A DK 325285 A DK325285 A DK 325285A DK 325285 A DK325285 A DK 325285A DK 325285 A DK325285 A DK 325285A DK 325285 A DK325285 A DK 325285A
Authority
DK
Denmark
Prior art keywords
treatment
Prior art date
Application number
DK325285A
Other languages
English (en)
Other versions
DK325285D0 (da
Inventor
Brian Morgan
Original Assignee
Beecham Wuelfing Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Wuelfing Gmbh & Co Kg filed Critical Beecham Wuelfing Gmbh & Co Kg
Publication of DK325285D0 publication Critical patent/DK325285D0/da
Publication of DK325285A publication Critical patent/DK325285A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK325285A 1984-07-19 1985-07-17 Behandlingsmetode DK325285A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848418430A GB8418430D0 (en) 1984-07-19 1984-07-19 Treatment

Publications (2)

Publication Number Publication Date
DK325285D0 DK325285D0 (da) 1985-07-17
DK325285A true DK325285A (da) 1986-01-20

Family

ID=10564129

Family Applications (1)

Application Number Title Priority Date Filing Date
DK325285A DK325285A (da) 1984-07-19 1985-07-17 Behandlingsmetode

Country Status (7)

Country Link
US (1) US4657910A (da)
EP (1) EP0173039A3 (da)
JP (2) JPS6140288A (da)
AU (1) AU581672B2 (da)
DK (1) DK325285A (da)
GB (1) GB8418430D0 (da)
ZA (1) ZA855399B (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4808619A (en) * 1983-07-27 1989-02-28 Beecham Group P.L.C. Di/tetra-hydroquinolines
GB8621869D0 (en) * 1986-09-11 1986-10-15 Beecham Group Plc Treatment
IL106861A (en) * 1986-12-31 1997-02-18 Hoechst Roussel Pharma Pentoxifylline metabolites and pharmaceutical formulations containing them for inhibiting the activity of interleukin-1 and leukocyte-derived cytokines
US4965271A (en) * 1986-12-31 1990-10-23 Hoechst Roussel Pharmaceuticals, Inc. Method of inhibiting the activity of leukocyte derived cytokines
US5096906A (en) * 1986-12-31 1992-03-17 University Of Virginia Alumni Patents Foundation Method of inhibiting the activity of leukocyte derived cytokines
JP2661666B2 (ja) * 1988-02-19 1997-10-08 ヘキスト薬品工業株式会社 抗消化性潰瘍剤
US5321029A (en) * 1988-11-14 1994-06-14 Beecham-Wuelfing Gmbh & Co.K.G. Xanthines
GB8921029D0 (en) * 1989-09-16 1989-11-01 Beecham Wuelfing Gmbh & Co Kg Novel treatment
US6420374B1 (en) 1990-11-30 2002-07-16 Fred Hutchinson Cancer Research Center Use of xanthines as immunosuppressants and to inhibit allograft reactions
AU6126098A (en) * 1997-11-28 1999-06-16 Nikolai Vasilievich Karsanov Anti-hypoxic and anti-ischemic drug
TW200804383A (en) * 2006-06-05 2008-01-16 Astrazeneca Ab New compounds

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH608236A5 (da) * 1974-01-22 1978-12-29 Wuelfing J A Fa
FR2387035A1 (fr) * 1977-04-12 1978-11-10 Cassenne Lab Sa Nouveau medicament destine notamment au traitement des troubles fonctionnels cerebraux
DE2967632D1 (en) * 1978-04-22 1986-12-04 Beecham Wuelfing Gmbh & Co Kg Use of a xanthine derivate in the manufacture of a medicament
IL59664A0 (en) * 1979-04-05 1980-06-30 Wuelfing J Kg Xanthine derivatives,process for their preparation and their use in pharmaceutical compositions
IL59665A0 (en) * 1979-04-05 1980-06-30 Wuelfing J Kg Xanthine derivatives,process for their preparation and their use in pharmaceutical compositions
US4225607A (en) * 1979-05-14 1980-09-30 Johann A. Wulfing Pharmaceutical composition containing a xanthine derivative
DE2929596A1 (de) * 1979-07-21 1981-02-05 Hoechst Ag Verfahren zur herstellung von oxoalkyl-xanthinen
EP0042706B1 (en) * 1980-06-21 1985-12-27 BEECHAM - WUELFING GmbH & Co. KG Xanthine derivatives, pharmaceutical compositions containing them and a process for their preparation

Also Published As

Publication number Publication date
GB8418430D0 (en) 1984-08-22
ZA855399B (en) 1987-03-25
EP0173039A2 (en) 1986-03-05
AU581672B2 (en) 1989-03-02
JPH02160720A (ja) 1990-06-20
DK325285D0 (da) 1985-07-17
US4657910A (en) 1987-04-14
EP0173039A3 (en) 1988-09-14
AU4517585A (en) 1986-01-23
JPS6140288A (ja) 1986-02-26

Similar Documents

Publication Publication Date Title
DK562585D0 (da) Behandling
AT380762B (de) Hoergeraet
AT379929B (de) Hoergeraet
DK325285D0 (da) Behandlingsmetode
ATA135485A (de) Maishaecksler
AT386724B (de) Haecksler
FI870944L (fi) Ytbehandlingsfoerfarande.
ATA237384A (de) Maehwerk
ATE36715T1 (de) 7-d-mandelamido-3-(1-sulfomethyltetrazol-5us840229
ATA45484A (de) Kimme
AT389296B (de) Elektrokoagulator
KR850008741U (ko) 수처리기
KR860001342U (ko) 배식구용 전광 살균기
BR8402733A (pt) Divisoria
SE8402161D0 (sv) Vilbenk for ryggbehandling
SE8402741D0 (sv) Skinnet
FI841831A0 (fi) Baeranordning foer urinpaose.
SE8405649D0 (sv) Tvettaggregat : olltvett
AR231237A1 (es) Calzado-patin
ATA104085A (de) Sterilisiergeraet
KR860003474U (ko) 휴지케이스
BR8400079A (pt) Trefina
SE8400006D0 (sv) Vermekulvert
PT7585Y (pt) Pinca-arganel
BR6401746U (pt) Televisor

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment